NCT04171687View on ClinicalTrials.gov

Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 21, 2019

Primary Completion Date

February 7, 2020

Study Completion Date

April 9, 2020

Conditions
Healthy
Interventions
DRUG

Clopidogrel 75mg

Clopidogrel 75 mg tablet

DRUG

Tegoprazan 50 mg

Tegoprazan 50 mg tablet

DRUG

RAPA113

RAPA113 tablet

Trial Locations (1)

Unknown

Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY